6T9S
Human Butyrylcholinesterase in complex with 2-(N-hydroxyimino)-N-[(1S)-3-{4-[(2-methyl-1H-imidazol-1-yl)methyl]-1H-1,2,3-triazol-1-yl}-1- phenylpropyl]acetamide
Summary for 6T9S
Entry DOI | 10.2210/pdb6t9s/pdb |
Descriptor | Cholinesterase, alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(5-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ... (8 entities in total) |
Functional Keywords | butyrylcholinesterase, complex, oxime, hydrolase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 62334.00 |
Authors | Brazzolotto, X.,Sinko, G.,Marakovic, N.,Knezevic, A. (deposition date: 2019-10-28, release date: 2020-07-15, Last modification date: 2024-01-31) |
Primary citation | Marakovic, N.,Knezevic, A.,Roncevic, I.,Brazzolotto, X.,Kovarik, Z.,Sinko, G. Enantioseparation, in vitro testing, and structural characterization of triple-binding reactivators of organophosphate-inhibited cholinesterases. Biochem.J., 477:2771-2790, 2020 Cited by PubMed: 32639532DOI: 10.1042/BCJ20200192 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.7 Å) |
Structure validation
Download full validation report